Crow Point Partners’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,886
Closed -$38K 234
2017
Q1
$38K Buy
1,886
+359
+24% +$7.56K 0.01% 246
2016
Q4
$32K Sell
1,527
-6,468
-81% -$114K 0.01% 231
2016
Q3
$126K Buy
+7,995
New +$105K 0.02% 195

Other funds holding BAK

Crow Point Partners's BAK Position: Q2 2017 in Review

Crow Point Partners sold out of Braskem (BAK) in Q2 2017, closing a stake of 1,886 shares — an estimated $38K sold.

Crow Point Partners first reported a position in BAK in Q3 2016 and held it in 3 quarters. The position peaked at $126K in Q3 2016. 84 funds tracked by Wall St. Rank hold BAK as of Q2 2017.

  • Crow Point Partners reported no remaining Braskem position as of Q2 2017 after selling out during the quarter.
  • Crow Point Partners sold 1,886 Braskem shares in Q2 2017, an estimated $38K.
  • Crow Point Partners first reported a position in Braskem in Q3 2016 and held it in 3 quarters.
  • Crow Point Partners's Braskem position peaked at $126K in Q3 2016.
  • 84 funds tracked by Wall St. Rank held Braskem as of Q2 2017.

Based on Crow Point Partners's 13F filing for Q2 2017, filed 17 Jul 2017.